Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice

被引:65
作者
Pan, LR
Tang, Q
Fu, Q
Hu, BR
Xiang, JZ [1 ]
Qian, JQ
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430030, Peoples R China
[2] Yunyang Med Coll, Dept Pharmacol, Shiyan 442000, Peoples R China
关键词
berberine; nitric oxide; protective agents; ethanol-induced disorders; stomach ulcer;
D O I
10.1111/j.1745-7254.2005.00186.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: To investigate the protective effects of berberine on ethanol-induced gastric ulcer in mice. Methods: Gastric ulcers were induced by oral ingestion of ethanol. Nitric oxide (NO) content was measured, and mRNA expression of endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) were analyzed by reverse transcription-polymerase chain reaction (RT-PCR). Results: The ulcer index (UI) at 1 h, 2 h, 3 h and 6 h after oral administration of ethanol was 23.8 +/- 1.4, 23.3 +/- 2.2, 22.3 +/- 1.2 and 20.8 +/- 1.1, respectively. The UI in the berberine-treated groups (5 mg/kg and 50 mg/kg) was less than the control group. The content of NO in the control group was 73.3 +/- 7.3 mu L/L, 94.0 +/- 9.2 mu L/L, 109.6 +/- 6.4 mu L/L and 138.2 +/- 10.2 mu L/L in gastric juice and 5.8 +/- 1.1 mu mol/g protein, 8.3 +/- 1.1 mu mol/g protein, 9.8 +/- 1.1 mu mol/g protein and 11.9 +/- 1.2 mu mol/g protein in gastric tissue at 1 h, 2 h, 3 h and 6 h, respectively, after the oral administration of ethanol. The content of NO in the berberine-treated groups (5 mg/kg and 50 mg/kg) was higher than the control group at 1 h after the oral administration of ethanol (P < 0.05), and was lower at 6 h (P < 0.05). Analysis by RT-PCR showed that expression of eNOS was inhibited but iNOS expression was enhanced by ethanol. However, the expression of eNOS could be enhanced and iNOS expression could be inhibited by berberine (P < 0.01). Conclusion: Berberine could significantly protect gastric mucosa from damage by ethanol. This effect may be related to the increased expression of eNOS mRNA and inhibited expression of iNOS mRNA.
引用
收藏
页码:1334 / 1338
页数:5
相关论文
共 24 条
  • [1] Role of nitric oxide in gastrointestinal inflammatory and ulcerative diseases:: Perspective for drugs development
    Barrachina, MD
    Panés, J
    Esplugues, JV
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (01) : 31 - 48
  • [2] Current roles of nitric oxide in gastrointestinal disorders
    Cho, CH
    [J]. JOURNAL OF PHYSIOLOGY-PARIS, 2001, 95 (1-6) : 253 - 256
  • [3] Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury
    Ding, HL
    Zhu, HF
    Dong, JW
    Zhu, WZ
    Yang, WW
    Yang, HT
    Zhou, ZN
    [J]. ACTA PHARMACOLOGICA SINICA, 2005, 26 (03) : 315 - 322
  • [4] Expression of constitutive nitric oxide synthase in rat and human gastrointestinal tract
    Fischer, H
    Becker, JC
    Boknik, P
    Huber, V
    Lüss, H
    Neumann, J
    Schmitz, W
    Domschke, W
    Stachura, J
    Konturek, JW
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1999, 1450 (03): : 414 - 422
  • [5] Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent
    Garhart, CA
    Heinzel, FP
    Czinn, SJ
    Nedrud, JG
    [J]. INFECTION AND IMMUNITY, 2003, 71 (02) : 910 - 921
  • [6] Expression and activities of three inducible enzymes in the healing of gastric ulcers in rats
    Guo, JS
    Cho, CH
    Wang, WP
    Shen, XZ
    Cheng, CL
    Koo, MWL
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (08) : 1767 - 1771
  • [7] HICANO H, 1998, FOREIGN MED SCI, V20, P31
  • [8] Mechanisms involved in protection afforded by L-arginine in Ibuprofen-induced gastric damage -: Role of nitric oxide and prostaglandins
    Jiménez, D
    Martin, MJ
    Pozo, D
    Alarcón, C
    Esteban, J
    Bruseghini, L
    Esteras, A
    Motilva, V
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (01) : 44 - 53
  • [9] Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels
    Kang, DG
    Sohn, EJ
    Kwon, EK
    Han, JH
    Oh, HC
    Lee, HS
    [J]. VASCULAR PHARMACOLOGY, 2002, 39 (06) : 281 - 286
  • [10] Vasorelaxant and antiproliferative effects of berberine
    Ko, WH
    Yao, XQ
    Lau, CW
    Law, WI
    Chen, ZY
    Kwok, W
    Ho, K
    Huang, Y
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 399 (2-3) : 187 - 196